| Financial Year |
March 31 2023 |
| Monetary Funds |
2,214,884,446.53 |
| Held-for-trading Financial Assets |
866,786,108.16 |
| Notes Receivable |
63,784,196.68 |
| Accounts Receivable |
2,848,809,955.18 |
| Advances to Suppliers |
344,913,219.83 |
| Other Receivables |
40,524,610.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,449,684.52 |
| Dividend Receivable |
-- |
| Inventories |
979,664,322.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
110,663,784.36 |
| Other Current Assets |
158,886,131.33 |
| Total Current Assets |
9,080,929,518.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
415,926,747.81 |
| Long-term Equity Investment |
1,004,334,691.62 |
| Investment Properties |
7,938,876.91 |
| Fixed Assetes |
200,921,370.70 |
| Under-construction Projects |
6,360,698.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
530,959,333.14 |
| R&D expenses |
93,054,745.21 |
| Goodwill |
168,692,707.32 |
| Long-Term Deferred and Prepaid Expenses |
38,140,645.52 |
| Deferred Income Tax Assets |
103,454,140.92 |
| Other Non-Current Assets |
50,453,750.00 |
| Sub-Total of Non-Current Assets |
5,414,083,995.67 |
| Total Assets |
14,495,013,513.91 |
| Short-Term Loans |
48,254,411.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,726,601,402.20 |
| Accounts Payable |
1,872,582,528.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,763,044.85 |
| Taxes Payable |
37,056,437.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
159,447,178.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,180,108.83 |
| Other Current Liabilities |
558,410,683.76 |
| Sub-Total of Current Liabilities |
5,045,346,401.79 |
| Long-term Loans |
222,570,573.05 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
147,194.54 |
| Deferred Income Tax Liabilities |
341,843,465.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
764,923,194.95 |
| Total Liabilities |
5,810,269,596.74 |
| Paid-In Capital(Or Share Stock) |
2,154,331,565.00 |
| Capital Surplus |
3,793,383,659.42 |
| Surplus Reserve |
219,711,166.76 |
| LESS:Treasury Stock |
167,447,293.43 |
| Undistributed Profits |
2,616,777,275.40 |
| Minority Stockholder's Interest |
7,242,141.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,677,501,775.97 |
| Owner's Equity（Stockholder's Equity） |
8,684,743,917.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,495,013,513.91 |
